Nuvectis Pharma, Inc. NVCT Business Segments — Labor And Related Expense

Similar metrics at other companies

LBR

LBRXClinical Trial — Direct Research And Development Expenses

$1.18M-88.8%

MPLTClinical Trial — Research And Development Expense

$24.82M+1,180%

DNTHPersonnel And Related Costs — Research And Development Expense

$8.64M+47.7%

GERNResearch and clinical expenses — R&D

$13M-5.1%

TYRAPersonnel Costs — Research And Development Expense

$11.79M+46.9%

BCRXCompensation and related personnel costs — Research and Development Expense (Excluding Acquired in Process Cost)

$27.09M+119%

Questions, answered.

What is Nuvectis Pharma, Inc.'s business segments — labor and related expense?

Nuvectis Pharma, Inc. (NVCT) reported business segments — labor and related expense of $2.07M in Q1 2026.

How has Nuvectis Pharma, Inc.'s business segments — labor and related expense changed year-over-year?

Nuvectis Pharma, Inc.'s business segments — labor and related expense increased by 20.3% year-over-year, from $1.72M to $2.07M.

What is the long-term trend for Nuvectis Pharma, Inc.'s business segments — labor and related expense?

Over 2 years (2023 to 2025), Nuvectis Pharma, Inc.'s business segments — labor and related expense has grown at a -6.9% compound annual growth rate (CAGR), from $8.61M to $7.46M.

What does business segments — labor and related expense mean?

Total compensation costs including salaries, benefits, and stock-based compensation for personnel directly involved in clinical development activities. This reflects the investment in human capital required to advance the company's drug pipeline.